TY - JOUR
T1 - Nanoparticle contrast-enhanced computed tomography and magnetic resonance imaging of vascularization of a subcutaneous niche for islet transplantation
AU - Capuani, Simone
AU - Campa-Carranza, Jocelyn Nikita
AU - Hernandez, Nathanael
AU - Menon, Renuka T.R.
AU - Bhavane, Rohan
AU - Rome, Gabrielle E.
AU - Devkota, Laxman
AU - Ghaghada, Ketan B.
AU - Annapragada, Ananth V.
AU - Chua, Corrine Ying Xuan
AU - Badachhape, Andrew A.
AU - Grattoni, Alessandro
N1 - Publisher Copyright:
© 2024 The Author(s). Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.
PY - 2024/12/13
Y1 - 2024/12/13
N2 - Revascularization plays a critical role in the successful engraftment of transplanted pancreatic islets, which are inherently rich in capillaries to meet their high metabolic demands. Innovative islet encapsulation strategies such as the NICHE (neovascularized implantable cell homing and encapsulation), generate a prevascularized transplantation site that allows for direct integration of the graft with the systemic circulation. Timing the transplantation is key to maximizing islet engraftment and survival, especially in diabetic individuals, who exhibit impaired wound healing. Therefore, in this study, we explored different methods to assess vascular development within NICHE in vivo in a non-invasive fashion. We effectively tracked neoangiogenesis using nanoparticle contrast-enhanced computed tomography (nCECT), observing a steady increase in vascularization over an 8-week period, which was confirmed histologically. Next, we estimated relative vascularization changes via T2 mapping with magnetic resonance imaging (MRI) before and after islet transplantation. On the first day post-transplantation, we measured a slight decrease in T2 values followed by a significant increase by day 14 attributable to islet revascularization. Our findings underscore the potential of non-invasive imaging techniques to provide insightful information on the readiness of the transplant site within cell encapsulation systems to support cell graft transplantation.
AB - Revascularization plays a critical role in the successful engraftment of transplanted pancreatic islets, which are inherently rich in capillaries to meet their high metabolic demands. Innovative islet encapsulation strategies such as the NICHE (neovascularized implantable cell homing and encapsulation), generate a prevascularized transplantation site that allows for direct integration of the graft with the systemic circulation. Timing the transplantation is key to maximizing islet engraftment and survival, especially in diabetic individuals, who exhibit impaired wound healing. Therefore, in this study, we explored different methods to assess vascular development within NICHE in vivo in a non-invasive fashion. We effectively tracked neoangiogenesis using nanoparticle contrast-enhanced computed tomography (nCECT), observing a steady increase in vascularization over an 8-week period, which was confirmed histologically. Next, we estimated relative vascularization changes via T2 mapping with magnetic resonance imaging (MRI) before and after islet transplantation. On the first day post-transplantation, we measured a slight decrease in T2 values followed by a significant increase by day 14 attributable to islet revascularization. Our findings underscore the potential of non-invasive imaging techniques to provide insightful information on the readiness of the transplant site within cell encapsulation systems to support cell graft transplantation.
KW - cell encapsulation
KW - computed tomography
KW - contrast-enhanced imaging
KW - islet transplantation
KW - magnetic resonance imaging
KW - revascularization
KW - T2-mapping
UR - http://www.scopus.com/inward/record.url?scp=85211907263&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85211907263&partnerID=8YFLogxK
U2 - 10.1002/btm2.10740
DO - 10.1002/btm2.10740
M3 - Article
AN - SCOPUS:85211907263
SN - 2380-6761
JO - Bioengineering and Translational Medicine
JF - Bioengineering and Translational Medicine
M1 - e10740
ER -